Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma
Clinical trial NCT04949113 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04949113
- Sponsor
- The Netherlands Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-08
- Primary completion
- 2024-01-12
- Enrollment
- 423
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.